These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22298895)

  • 1. Genetically modified mouse models for biomarker discovery and preclinical drug testing.
    Kucherlapati R
    Clin Cancer Res; 2012 Feb; 18(3):625-30. PubMed ID: 22298895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered models have advantages over xenografts for preclinical studies.
    Becher OJ; Holland EC
    Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs.
    Frijhoff AF; Conti CJ; Senderowicz AM
    Mol Carcinog; 2004 Apr; 39(4):183-94. PubMed ID: 15057870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.
    Hansen K; Khanna C
    Eur J Cancer; 2004 Apr; 40(6):858-80. PubMed ID: 15120042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mighty mouse: genetically engineered mouse models in cancer drug development.
    Sharpless NE; Depinho RA
    Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
    Hoffman RM
    Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling cancer in mice.
    Jackson-Grusby L
    Oncogene; 2002 Aug; 21(35):5504-14. PubMed ID: 12154411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future of early detection of lung cancer: the role of mouse models.
    Shaw AT; Kirsch DG; Jacks T
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4999s-5003s. PubMed ID: 16000603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models.
    Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW
    Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of human cancer as tools in drug development.
    Holland EC
    Cancer Cell; 2004 Sep; 6(3):197-8. PubMed ID: 15380508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine. Building better mouse models for studying cancer.
    Marx J
    Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
    [No Abstract]   [Full Text] [Related]  

  • 14. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
    Kelland LR
    Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 50 years of preclinical anticancer drug screening: empirical to target-driven approaches.
    Suggitt M; Bibby MC
    Clin Cancer Res; 2005 Feb; 11(3):971-81. PubMed ID: 15709162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models of metastasis in drug discovery.
    Talmadge JE
    Methods Mol Biol; 2010; 602():215-33. PubMed ID: 20012401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preclinical evaluation of anticancer drugs: a model remaining a model!].
    Lavelle F
    Bull Cancer; 1998 Oct; 85(10):837-42. PubMed ID: 9835860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered mouse models in drug discovery research.
    Sacca R; Engle SJ; Qin W; Stock JL; McNeish JD
    Methods Mol Biol; 2010; 602():37-54. PubMed ID: 20012391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches.
    van Miltenburg MH; Jonkers J
    Curr Opin Genet Dev; 2012 Feb; 22(1):21-7. PubMed ID: 22321988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.